Characterization of Insufficient Responders to Anti-Tumor Necrosis Factor Therapies in Patients With Moderate to Severe Psoriasis: Real-World Data From the US Corrona Psoriasis Registry

Journal of Dermatological Treatment - United Kingdom
doi 10.1080/09546634.2019.1656797